The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of tricyclic cores for kinase inhibition.EBI
Abbott Bioresearch Center
Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.EBI
Abbott Bioresearch Center
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.EBI
Abbott Bioresearch Center
Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3.EBI
Abbott Bioresearch Center
Discovery of thieno[2,3-c]pyridines as potent COT inhibitors.EBI
Abbott Bioresearch Center
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.EBI
Abbott Bioresearch Center
Discovery of thienopyridines as Src-family selective Lck inhibitors.EBI
Abbott Bioresearch Center
Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.EBI
Abbott Bioresearch Center
A 13C NMR approach to categorizing potential limitations of alpha,beta-unsaturated carbonyl systems in drug-like molecules.EBI
Abbott Bioresearch Center
A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection.EBI
Abbott Bioresearch Center
Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck.EBI
Abbott Bioresearch Center
Substituted pyridines as sodium channel blockersBDB
TBA